研究领域
1. 靶向纳米制剂的构建与评价
2. 新剂型、新制剂研发
3. 生物药剂学和药物动力学
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Liu ZJ, Jiang DB, Tian LL, Yin JJ, Huang JM, Weng WY*. Intestinal permeability of forskolin by in situ single pass perfusion in rats. Planta Med. 2012, 78(7): 698-702.
田非非, 江东波, 刘真君, 翁伟宇*. 小檗碱脂肪酸盐的制备及理化性质研究. 中国医药工业杂志, 2011, 42(9): 665-668.
田非非, 江东波, 刘真君, 李风云, 翁伟宇*. 月桂酸小檗碱肠道给药的相对生物利用度研究. 中国现代应用药学, 2011, 28(12): 1117-1121.
Huang JM, Wang GQ, Jin YE, Shen T, Weng WY*. Determination of palmatine in canine plasma by liquid chromatography-tandem mass spectrometry with solid-phase extraction. J Chromatogr B, 2007, 854(1-2): 279-285.
Huang JM, Li N, Yu YQ, Weng WY*, Huang XB. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC. J Pharm Biomed Anal, 2006, 40(2): 465-471.
Weng WY, Xu HN, Huang JM, Wang GQ, Shen T, Zhang JF. A pharmacokinetic study of intramuscular administration of bulleyaconitine A in healthy volunteers. Biol Pharm Bull, 2005, 28(4): 747-749.
Weng WY, Xu HN, Huang JM, Wang GQ, Shen T, Zhang JF. Determination of bulleyaconitine A in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry. J Chromatogr B, 2005, 816(1-2): 315-320.
Huang JM, Weng WY*, Huang XB, Ji YH, Chen E. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats. Eur J Drug Metab Pharmacokinet, 2005, 30(3): 165-170.
Huang JM, Weng WY*, Cao D, Huang XB, Wang J, Yu H. Determination of palmatine in rabbit plasma by RP-HPLC with solid-phase extraction. Chromatographia, 2005, 62(9/10): 471-474.
翁伟宇,徐惠南,力弘,沈腾,张建芳,邵丽,钱丽华. 草乌甲素脂质体的皮肤渗透性及抗炎镇痛作用. 中国临床药学杂志. 2003,12(3): 131-135.